ESC Preventive Cardiology 2024: Delving into burning issues about heart disease and much more

The hottest science in the prevention of heart disease awaits at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).

Duke researchers find app improves autism screening in NIH-funded study

Dive Brief: A tablet-based app powered by computer vision and machine learning may improve screening for autism, according to a paper in Nature Medicine. Researchers

October 4, 2023

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma – Biotech Investments

Issuer: CureVac / Key word(s): Study 15.08.2024 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Advances Cancer Vaccine

August 16, 2024

Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug

Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental drug for a common skin disorder succeeded in a late-stage

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.